A Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

A Study of KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing Preparations

NCT03703570 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety, Tolerability and Efficacy of MT101-5 in Subjects with Early Parkinson's Disease

NCT06175767 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Study of MK0657 in Parkinson's Disease Patients (0657-006)

NCT00505843 ·Status: COMPLETED ·Phase: PHASE1

2 Year Study to Evaluate the Effects of GPI 1485 on [123I]b-CIT/SPECTScanning and Clinical Efficacy in Patients With PD

NCT00209508 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety and Efficacy of IPX203 in Parkinson's Disease Participants With Motor Fluctuations

NCT03670953 ·Status: COMPLETED ·Phase: PHASE3

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ODM-103 in Healthy Volunteers

NCT01688089 ·Status: COMPLETED ·Phase: PHASE1

A Study of Single and Multiple Doses of KW-6356 in Healthy Subjects

NCT03830528 ·Status: COMPLETED ·Phase: PHASE1

A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Safety, Tolerability and Efficacy of E2007 in Parkinson's Disease Patients With "Wearing Off" Motor Fluctuations and "On" Period Dyskinesias

NCT01172379 ·Status: COMPLETED ·Phase: PHASE2

First-in-man Study of Single Ascending Dose of a New Drug for Neurological Disorders

NCT02719197 ·Status: COMPLETED ·Phase: PHASE1

Phase I Study to Evaluate KP405 in Healthy and Parkinson's Disease Patients

NCT06189170 ·Status: RECRUITING ·Phase: EARLY_PHASE1

A Study to Assess the Safety of GRF6021 Infusions in Subjects With Parkinson's Disease and Cognitive Impairment

NCT03713957 ·Status: COMPLETED ·Phase: PHASE2

Placebo-Controlled Double-Blind Crossover Comparative Study of KW-6500

NCT01058291 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of MT-5199 in Subjects With Tardive Dyskinesia

NCT03176771 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Trial of Valproic Acid in Patients With Progressive Supranuclear Palsy (Depakine)

NCT00385710 ·Status: COMPLETED ·Phase: PHASE2

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of PF-06649751 in Subjects With Idiopathic Parkinson's Disease

NCT02373072 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112 Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy

NCT01049399 ·Status: COMPLETED ·Phase: NA

Efficacy, Safety, and Pharmacokinetics/Pharmacodynamic Study of L-Dopa/Carbidopa To Treat Parkinson's Disease

NCT00558337 ·Status: COMPLETED ·Phase: PHASE2

The Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations

NCT00286897 ·Status: COMPLETED ·Phase: PHASE3

First-in-man Study of Single and Multiple Ascending Doses of a New Drug for Neurological Disorders

NCT02702648 ·Status: COMPLETED ·Phase: PHASE1

A Pilot Trial of Lithium in Subjects With Progressive Supranuclear Palsy or Corticobasal Degeneration

NCT00703677 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Evaluate the Efficacy of 18 to 24mg/Day Ropinirole Controlled Release (CR) Tablets in Early and Advanced Parkinson's Disease (PD) Patients.

NCT01929317 ·Status: TERMINATED ·Phase: PHASE3

PF-06669571 In Subjects With Idiopathic Parkinson's Disease

NCT02565628 ·Status: COMPLETED ·Phase: PHASE1

A Dose-escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetic of LPM3770164 in Healthy Subjects

NCT05238701 ·Status: COMPLETED ·Phase: PHASE1

A Phase 3 Study of TVP-1012 (1 mg) in Early Parkinson's Disease Patients

NCT02337725 ·Status: COMPLETED ·Phase: PHASE3

Gastric Retentive Carbidopa/ Levodopa in Parkinson's Patients; a One Year, Open Label, Safety Extension Study

NCT00947037 ·Status: WITHDRAWN ·Phase: PHASE2